522 related articles for article (PubMed ID: 26515260)
1. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
4. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
5. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
6. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
Kibria G; Hatakeyama H; Harashima H
Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
[TBL] [Abstract][Full Text] [Related]
7. Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.
Niazi M; Zakeri-Milani P; Najafi Hajivar S; Soleymani Goloujeh M; Ghobakhlou N; Shahbazi Mojarrad J; Valizadeh H
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1021-33. PubMed ID: 27267126
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.
Gupta P; Jani KA; Yang DH; Sadoqi M; Squillante E; Chen ZS
Expert Opin Drug Metab Toxicol; 2016; 12(3):281-9. PubMed ID: 26799671
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers.
Dawar S; Singh N; Kanwar RK; Kennedy RL; Veedu RN; Zhou SF; Krishnakumar S; Hazra S; Sasidharan S; Duan W; Kanwar JR
Drug Discov Today; 2013 Dec; 18(23-24):1292-300. PubMed ID: 24055842
[TBL] [Abstract][Full Text] [Related]
12. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology applied to overcome tumor drug resistance.
Gao Z; Zhang L; Sun Y
J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
15. [Progress in the study of micelle delivery system reversing multidrug resistance].
Diao YY; Han M; Chen DW; Gao JQ
Yao Xue Xue Bao; 2009 Jul; 44(7):710-5. PubMed ID: 19806907
[TBL] [Abstract][Full Text] [Related]
16. Overcoming cancer multidrug resistance by codelivery of doxorubicin and verapamil with hydrogel nanoparticles.
Qin M; Lee YE; Ray A; Kopelman R
Macromol Biosci; 2014 Aug; 14(8):1106-15. PubMed ID: 24771682
[TBL] [Abstract][Full Text] [Related]
17. Overcoming multidrug resistance with nanomedicines.
Ganoth A; Merimi KC; Peer D
Expert Opin Drug Deliv; 2015 Feb; 12(2):223-38. PubMed ID: 25224685
[TBL] [Abstract][Full Text] [Related]
18. Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment.
Iangcharoen P; Punfa W; Yodkeeree S; Kasinrerk W; Ampasavate C; Anuchapreeda S; Limtrakul P
Arch Pharm Res; 2011 Oct; 34(10):1679-89. PubMed ID: 22076768
[TBL] [Abstract][Full Text] [Related]
19. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
Ho BN; Pfeffer CM; Singh ATK
Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]